$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics

Journal of controlled release : official journal of the Controlled Release Society, v.267, 2017년, pp.172 - 180  

Lee, Na Kyeong (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea) ,  Lee, Eun Jung (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea) ,  Kim, Soyoun (Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea) ,  Nam, Gi-hoon (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea) ,  Kih, Minwoo (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea) ,  Hong, Yeonsun (Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea) ,  Jeong, Cherlhyun (Center for) ,  Yang, Yoosoo ,  Byun, Youngro ,  Kim, In-San

Abstract AI-Helper 아이콘AI-Helper

Ferritin nanocages are of particular interest as a novel platform for drug and vaccine delivery, diagnosis, biomineralization scaffold and more, due to their perfect and complex symmetry, ideal physical properties, high biocompatibility, low toxicity profiles as well as easy manipulation by genetic ...

주제어

참고문헌 (55)

  1. Adv. Drug Deliv. Rev. Lee 106 157 2016 10.1016/j.addr.2016.03.002 Bioengineered protein-based nanocage for drug delivery 

  2. Curr. Opin. Biotechnol. Molino 28 75 2014 10.1016/j.copbio.2013.12.007 Caged protein nanoparticles for drug delivery 

  3. Nano Schoonen 6 7124 2014 Functionalization of protein-based nanocages for drug delivery applications 

  4. Small MaHam 5 1706 2009 10.1002/smll.200801602 Protein-based nanomedicine platforms for drug delivery 

  5. Chem. Soc. Rev. Pieters 45 24 2016 10.1039/C5CS00157A Natural supramolecular protein assemblies 

  6. Biomater. Sci. Estrada 3 787 2015 10.1039/C5BM00052A Protein nanoparticles for therapeutic protein delivery 

  7. Pharmacol. Res. Truffi 107 57 2016 10.1016/j.phrs.2016.03.002 Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer 

  8. Chem. Rev. Jutz 115 1653 2015 10.1021/cr400011b Ferritin: a versatile building block for bionanotechnology 

  9. Arch. Biochem. Biophys. Stefanini 325 58 1996 10.1006/abbi.1996.0007 Thermal stability of horse spleen apoferritin and human recombinant H apoferritin 

  10. Nucleic Acids Res. Ahn 33 3751 2005 10.1093/nar/gki692 Heterologous gene expression using self-assembled supra-molecules with high affinity for HSP70 chaperone 

  11. Biomacromolecules Kim 12 1629 2011 10.1021/bm200026v pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly 

  12. Biophys. J. Takahashi 84 2256 2003 10.1016/S0006-3495(03)75031-0 Functional properties of threefold and fourfold channels in ferritin deduced from electrostatic calculations 

  13. J. Struct. Biol. Pan 166 22 2009 10.1016/j.jsb.2008.12.001 3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images 

  14. Angew. Chem. Int. Ed. Lin 50 1569 2011 10.1002/anie.201006757 Hybrid ferritin nanoparticles as activatable probes for tumor imaging 

  15. Small Kwon 12 4241 2016 10.1002/smll.201600917 Enhanced in vivo tumor detection by active tumor cell targeting using multiple tumor receptor-binding peptides presented on genetically engineered human ferritin nanoparticles 

  16. Adv. Mater. Lee 24 4739 2012 10.1002/adma.201200728 A novel bioassay platform using ferritin-based nanoprobe hydrogel 

  17. Biomacromolecules Kim 17 1150 2016 10.1021/acs.biomac.5b01753 Designing peptide bunches on nanocage for bispecific or superaffinity targeting 

  18. Biomater. Sci. Luo 3 1386 2015 10.1039/C5BM00067J Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery 

  19. Biomaterials Kang 33 5423 2012 10.1016/j.biomaterials.2012.03.055 Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform 

  20. Nanomed. Nanotech. Biol. Med. Han 10 561 2014 10.1016/j.nano.2013.11.003 Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development 

  21. Angew. Chem. Int. Ed. Aime 41 1017 2002 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging 

  22. Adv. Mater. Uchida 21 458 2009 10.1002/adma.200801209 Intracellular distribution of macrophage targeting ferritin-iron oxide nanocomposite 

  23. Nano Lett. Lin 11 814 2011 10.1021/nl104141g Chimeric ferritin nanocages for multiple function loading and multimodal imaging 

  24. Cancer Res. Crich 66 9196 2006 10.1158/0008-5472.CAN-06-1728 Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe 

  25. Chem. Commun. Yan 4579 2008 10.1039/b810949d Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy 

  26. Proc. Nat. Acad. Sci. U. S. A. Liang 111 14900 2014 10.1073/pnas.1407808111 H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection 

  27. ACS Nano Zhen 7 4830 2013 10.1021/nn305791q RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors 

  28. J. Control. Release Bellini 196 184 2014 10.1016/j.jconrel.2014.10.002 Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in cancer cells 

  29. Chem. Commun. Yang 3453 2007 10.1039/b705326f Encapsulation of platinum anticancer drugs by apoferritin 

  30. ACS Nano Jeon 7 7462 2013 10.1021/nn403184u Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity 

  31. Adv. Mater. Lee 27 6637 2015 10.1002/adma.201503093 A double-chambered protein nanocage loaded with thrombin receptor agonist peptide (TRAP) and gamma-carboxyglutamic acid of protein C (PC-Gla) for sepsis treatment 

  32. Adv. Mater. Barreto 23 H18 2011 10.1002/adma.201100140 Nanomaterials: applications in cancer imaging and therapy 

  33. Adv. Drug Deliv. Rev. Aggarwal 61 428 2009 10.1016/j.addr.2009.03.009 Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy 

  34. Am. J. Physiol. Cell Physiol. Fisher 293 C641 2007 10.1152/ajpcell.00599.2006 Ferritin: a novel mechanism for delivery of iron to the brain and other organs 

  35. J. Exp. Med. Chen 202 955 2005 10.1084/jem.20042433 TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis 

  36. Blood Worwood 60 827 1982 10.1182/blood.V60.4.827.827 The clearance of 131I-human plasma ferritin in man 

  37. Biochim. Biophys. Acta Mack 843 164 1985 10.1016/0304-4165(85)90135-7 Characterization of the binding of ferritin to the rat liver ferritin receptor 

  38. Biomaterials Mirshafiee 75 295 2016 10.1016/j.biomaterials.2015.10.019 Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake 

  39. Int. J. Nanomedicine Vannucci 7 1489 2012 Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles 

  40. Langmuir Tsukamoto 29 12737 2013 10.1021/la4029595 Effect of PEGylation on controllably spaced adsorption of ferritin molecules 

  41. Biomacromolecules Falvo 17 514 2016 10.1021/acs.biomac.5b01446 Improved doxorubicin encapsulation and pharmacokinetics of ferritin-fusion protein nanocarriers bearing proline, serine, and alanine elements 

  42. J. Control. Release Fracasso 239 10 2016 10.1016/j.jconrel.2016.08.010 Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness 

  43. Nat. Biotechnol. Schellenberger 27 1186 2009 10.1038/nbt.1588 A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner 

  44. Annu. Rev. Biophys. Biomol. Struct. Marti-Renom 29 291 2000 10.1146/annurev.biophys.29.1.291 Comparative protein structure modeling of genes and genomes 

  45. Nucleic Acids Res. Maupetit 37 W498 2009 10.1093/nar/gkp323 PEP-FOLD: an online resource for de novo peptide structure prediction 

  46. Adv. Funct. Mat. Lee 25 1279 2015 10.1002/adfm.201403680 Engineered Proteinticles for targeted delivery of siRNA to cancer cells 

  47. J. Nucl. Med. Haeckel 55 508 2014 10.2967/jnumed.113.128108 XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation 

  48. J. Pharm. Sci. Cleland 101 2744 2012 10.1002/jps.23229 A novel long-acting human growth hormone fusion protein (vrs-317): enhanced in vivo potency and half-life 

  49. Bioconjug. Chem. Ding 25 1351 2014 10.1021/bc500215m Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility 

  50. Curr. Opin. Drug Discov. Dev. Gaberc-Porekar 11 242 2008 Obstacles and pitfalls in the PEGylation of therapeutic proteins 

  51. Proc. Nat. Acad. Sci. U. S. A. Gross 97 11990 2000 10.1073/pnas.97.22.11990 The structure of the chromophore within DsRed, a red fluorescent protein from coral 

  52. Curr. Drug Metab. Wang 11 129 2010 10.2174/138920010791110827 Nanoparticles for tumor targeted therapies and their pharmacokinetics 

  53. J. Appl. Crystallogr. Smilgies 48 1604 2015 10.1107/S1600576715015551 Molecular weight-gyration radius relation of globular proteins: a comparison of light scattering, small-angle X-ray scattering and structure-based data 

  54. J. Immunol. Storni 172 1777 2004 10.4049/jimmunol.172.3.1777 Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects 

  55. Eur. J. Immunol. Goldinger 42 3049 2012 10.1002/eji.201142361 Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients 

LOADING...

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트